FOLH1 and Familial prostate cancer: In vitro, the antibody-based PSMA-TTC was rapidly internalized in a target-dependent manner, selectively reduced PSMA-expressing cell viability, and induced double-stranded DNA breaks, cell cycle arrest (G2/M phase), and apoptosis in prostate cancer cells (61).